Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
about
Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic SystemsA Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human PrimatesX-ray-computed tomography contrast agentsLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis
P2860
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Complement activation-related ...... ugs, and radiocontrast agents.
@ast
Complement activation-related ...... ugs, and radiocontrast agents.
@en
Complement activation-related ...... ugs, and radiocontrast agents.
@nl
type
label
Complement activation-related ...... ugs, and radiocontrast agents.
@ast
Complement activation-related ...... ugs, and radiocontrast agents.
@en
Complement activation-related ...... ugs, and radiocontrast agents.
@nl
prefLabel
Complement activation-related ...... ugs, and radiocontrast agents.
@ast
Complement activation-related ...... ugs, and radiocontrast agents.
@en
Complement activation-related ...... ugs, and radiocontrast agents.
@nl
P1476
Complement activation-related ...... rugs, and radiocontrast agents
@en
P2093
P304
P577
2001-01-01T00:00:00Z